The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update

Canadian Pharmacists Journal

Volumn 148, Issue 4, 2015, Pages 180-186

  Houle, Sherilyn K D ^a   Padwal, Raj ^b   Poirier, Luc ^c   Tsuyuki, Ross T ^b,d  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; VARENICLINE;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE METER; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; DIASTOLIC BLOOD PRESSURE; EDUCATION PROGRAM; FOLLOW UP; HUMAN; HYPERTENSION; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACIST; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS;

EID: 84938901104     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.1177/1715163515586847     Document Type: Review

References (31)

1. N.R.CampbellE.BurgessB.C.K.Choi. Methods and an overview of the Canadian recommendations. CMAJ1999;160(9 suppl):S1-S6.
2. S.S.DaskalopoulouD.M.RabiK.B.Zarnke. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention and treatment of hypertension. Can J Cardiol. 2015;31(5):549-68.
3. F.A.McAlisterK.WilkinsM.Joffres. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ2011;183(9):1007-13.
4. M.A.Chisholm-BurnsJ.Kim LeeC.A.Spivey. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care2010;48:923-33.
5. V.SantschiA.ChioleroB.Burnand. Impact of pharmacist care in the management of cardiovascular disease risk factors: s systematic review and meta-analysis of randomized trials. Arch Intern Med2011;171:1441-53.
6. V.SantschiA.ChioleroG.Paradis. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and metaanalysis of randomized controlled trials. Diabetes Care2012;35:2706-17.
7. V.SantschiA.ChioleroA.L.Colosimo. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc2014;3:e000718.
8. R.TsuyukiS.HouleT.Charrois. A randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Can Pharm J (Ott)2014;147:S18.
9. N.PojskicM.JacksonA.MalekS.CiminoImpact of community pharmacist interventions in hypertension management on patient outcomes: a randomized controlled trial. Can Pharm J (Ott)2014;147:S17.
10. S.K.D.HouleR.T.TsuyukiN.R.C.Campbell. The Canadian Hypertension Education Program (CHEP) 2011 Guidelines for Pharmacists. Can Pharm J (Ott)2011;144:295-304.
11. S.K.D.HouleR.PadwalR.T.Tsuyuki. The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: an update. Can Pharm J (Ott)2013;146:146-50.
12. S.K.D.HouleR.PadwalL.PoirierR.T.Tsuyuki. The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: an update. Can Pharm J (Ott)2014;147:203-8.
13. M.G.MyersJ.KaczorowskiM.DawesM.GodwinAutomated office blood pressure measurement in primary care. Can Fam Phys2014;60:127-32.
14. L.BeckettM.GodwinThe BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord2005;5:18.
15. E.A.AndreadisG.D.AgaliotisE.T.Angelopoulos. Automated office blood pressure and 24-h ambulatory measurements are equally associated with left ventricular mass index. Am J Hypertens2011;24:661-6.
16. G.MuleG.CaimiS.Cottone. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk2002;9:123-9.
17. T.OhkuboM.KikuyaH.Metoki. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring: 10-year follow-up from the Ohasama Study. J Am Coll Cardiol2005;46:508-15.
18. S.S.FranklinL.ThijsT.W.Hansen. White-coat hypertension: new insights from recent studies. Hypertension2013;62:982-7.
19. M.R.HanninenT.J.NiiranenP.J.Puukka. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens2011;29:1880-8.
20. A.AndalibS.AkhtariR.Rigal. Determinants of masked hypertension in hypertensive patients treated in a primary care setting. Intern Med J2012;42:260-6.
21. J.BarochinerP.E.CuffaroL.S.Aparicio. Predictors of masked hypertension among treated hypertensive patients: an interesting association with orthostatic hypertension. Am J Hypertens2013;26:872-8.
22. F.A.McAlisterC.RobitailleC.Gillespie. The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States. Can J Cardiol2013;29:598-605.
23. L.F.SteadD.BuitragoN.Preciado. Physician advice for smoking cessation. Cochrane Database System Rev2013,(5):CD000165.
24. K.CahillS.StevensR.PereraT.LancasterPharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database System Rev2013;(5):CD009329.
25. S.H.JeeI.SuhI.S.KimL.J.AppelSmoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA1999;282:2149-55.
26. I.NjolstadE.ArnesenP.G.Lund-LarsenSmoking, serum lipids, blood pressure and sex differences in myocardial infarction: a 12-year follow-up of the Finnmark Study. Circulation1996;93:450-6.
27. E.PrescottM.HippeP.Schnohr. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ1998;316:1043.
28. S.YusufS.HawkenS.Ounpuu. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet2004;364:937-52.
29. R.R.HuxleyM.WoodwardCigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet2011;378:1297-305.
30. Q.QiaoM.TervahautaA.NissinenJ.TuomilehtoMortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J2000; 21:1621-6.
31. M.SabaJ.DiepB.SainiT.DhippayomMeta-analysis of the effectiveness of smoking cessation interventions in community pharmacy. J Clin Pharm Ther2014;39:240-7.